1-20 of 1452
color
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Cryptic insertion of KMT2A , a rare t(9;11) variant

Nada Assaf, Christine Terré
Journal: Blood
Blood (2021) 137 (13): 1843.
https://doi.org/10.1182/blood.2020010442
Published: 2021
Journal Articles

DC Vaccination Induces Antigen Specific Immune Responses in AML Patients: A 1-Year Interim Assessment

Judith Eckl, PhD, Silke Raffegerst, PhD, Frauke Schnorfeil, PhD, Petra Prinz-Schulz, PhD, Christiane Fingerhut, Yngvar Floisand, MD PhD, Dag Josefsen, Iris Bigalke, MD, Kai Pinkernell, MDMBA, Gunnar Kvalheim, MD PhD, Dolores Schendel, Prof., Anna Tafuri, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3923.
https://doi.org/10.1182/blood-2019-129749
Published: 2019
Journal Articles

Sequential Combination of Inotuzumab Ozogamicin (InO) with Low-Intensity Chemotherapy (Mini-hyper-CVD) with or without Blinatumomab Is Highly Effective in Patients (pts) with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia (ALL) in First Relapse

Koji Sasaki, MD, Hagop M. Kantarjian, MD, Farhad Ravandi, MD, Nicholas J. Short, MD, Partow Kebriaei, MD, Xuelin Huang, PhD, Michael E. Rytting, MD, Nitin Jain, MD, Marina Y Konopleva, MD PhD, Guillermo Garcia-Manero, MD, Richard E. Champlin, MD, Tapan M. Kadia, MD, Jorge E. Cortes, MD, Zeev E. Estrov, MD, Koichi Takahashi, MD, Christopher Loiselle, BS, Corabelle Encarnacion, RDC, Meagan Rostykus, RN, Rita Khouri, Patrice Nasnas, MD, Jovitta Jacob, RN, Monica Kwari, BSN, Rebecca Garris, MSc, Elias Jabbour, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3806.
https://doi.org/10.1182/blood-2019-129018
Published: 2019
Journal Articles

Isolation and Characterization of a CD34 + Sub-Clone in B-Cell Lymphoma

Ayad Al-Katib, MD, Ebrahim Abdul Shukkur, PhD, Ali M Gabali, MD PhD, ALI Raufi, MD, Salah Ebrahim, MD, Mustapha Kandouz, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3970.
https://doi.org/10.1182/blood-2019-130738
Published: 2019
Journal Articles

Duobody-CD3xCD20 Induces Potent Anti-Tumor Activity in Malignant Lymph Node B Cells from Patients with DLBCL, FL and MCL Ex Vivo , Irrespective of Prior Treatment with CD20 Monoclonal Antibodies

Hilma J Van Der Horst, MSc, A. Vera de Jonge, Ida H Hiemstra, PhD, Anne T Gelderloos, MSc, Daniella RAI Berry, Nathalie J Hijmering, Daphne de Jong, Prof Dr, Martine E.D. Chamuleau, Sonja Zweegman, MD PhD, Esther CW Breij, DPhil, Margaretha GM Roemer, PhD, Tuna Mutis
Journal: Blood
Blood (2019) 134 (Supplement_1): 4066.
https://doi.org/10.1182/blood-2019-125765
Published: 2019
Journal Articles

Utilizing Multiparametric Flow Cytometry to Identify Patients with Primary Plasma Cell Leukemia at Diagnosis

Laura A Evans, Dragan Jevremovic, MD PhD, Bharat Nandakumar, Francis K. Buadi, MB, CHB, Angela Dispenzieri, MD, David Dingli, MD PhD, Martha Q. Lacy, MD, Suzanne R. Hayman, MD, Prashant Kapoor, MD, Ronald S. Go, MD, Nelson Leung, MD, Amie Fonder, PA-C, MS, Miriam A. Hobbs, APRN, CNP, DNP, Yi L. Hwa, APRN, CNP, DNP, Eli Muchtar, MD, Rahma M Warsame, MD, Taxiarchis Kourelis, MD, Stephen J Russell, MD PhD, John A. Lust, MD PhD, Yi Lin, MD PhD, Mustaqeem Siddiqui, MD, Robert A. Kyle, MD, Morie A Gertz, MD, S. Vincent Rajkumar, MD, Shaji K. Kumar, MD, Wilson I Gonsalves, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4334.
https://doi.org/10.1182/blood-2019-126777
Published: 2019
Journal Articles

A Randomized Phase 2 Study Comparing Acalabrutinib with or without Obinutuzumab in the Treatment of Early Stage High Risk Patients with Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)

Sameer A. Parikh, MD, Eli Muchtar, MD, Betsy Laplant, MS, Wei Ding, MD PhD, Sikander Ailawadhi, MD, Amber Koehler, PA-C, MS, Timothy G. Call, MD, Saad S. Kenderian, MD, Jose F. Leis, MD PhD, Amie Fonder, PA-C, MS, Min Shi, MD PhD, Asher A. Chanan-Khan, MD, Adam Pettinger, Thomas E. Witzig, MD, Carrie A. Thompson, MD, Jose C Villasboas, Jessica M Sholes, Curtis A. Hanson, MD, Esteban Braggio, PhD, Kay L. Medina, PhD, Susan L. Slager, PhD, Neil E. Kay, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4306.
https://doi.org/10.1182/blood-2019-123824
Published: 2019
Journal Articles

Reduced Antigen Presentation May Contribute to Immunomodulatory Drug Resistance in Multiple Myeloma

David G. Coffey, MD, Ola Landgren, MD PhD, Yuexin Xu, PhD, Dickran Kazandjian, MD, Trevor J. Pugh, PhD, Sacha Gnjatic, PhD, Edus H. Warren, MD PhD, Damian J. Green, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4367.
https://doi.org/10.1182/blood-2019-126222
Published: 2019
Journal Articles

Next Generation Flow Cytometry Provides a Standardized, Highly Sensitive and Informative Method for the Analysis of Circulating Plasma Cells in Newly Diagnosed Multiple Myeloma: A Single Center Study in 182 Patients

Evangelos Terpos, MD PhD, Ioannis V. Kostopoulos, Aristea-Maria Papanota, MD, Konstantinos Papadimitriou, BSc, Panagiotis Malandrakis, MD, Paraskevi Micheli, BSc, Ioannis Ntanasis-Stathopoulos, MD, Despina Fotiou, MD, Andreas Metousis, BSc, Nikolaos Kanellias, MD, Magdalini Migkou, MD, Evangelos Eleutherakis-Papaiakovou, MD, Maria Gavriatopoulou, MD, Eftathios Kastritis, Ourania E. Tsitsilonis, MD PhD, Meletios A. Dimopoulos, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4338.
https://doi.org/10.1182/blood-2019-127989
Published: 2019
Journal Articles

Donor and Host Coexpressing KIR Ligands Promote NK Education Post Allogeneic Hematopoietic Stem Cell Transplantation

Xingxing Yu, Xiang-Yu Zhao, Zhengli Xu, Xunhong Cao, Mingrui Huo, Xiao-Su Zhao, Ying-Jun Chang, Yu Wang, Xiaohui Zhang, Lanping Xu, Kaiyan Liu, Xiaojun Huang, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4519.
https://doi.org/10.1182/blood-2019-129609
Published: 2019
Journal Articles

Difference in Involved and Uninvolved Free Light Chain (dFLC) of Less Than 1mg/DL Early Post Risk Adapted Melphalan and Autologous Stem Cell Transplantation (RA-ASCT) Predicts Renal Response at 1 Year in Light Chain (AL) Amyloidosis

Sneha Purvey, MD, Kenneth Seier, MS, Sean M. Devlin, PhD, Josel D Ruiz, MPH, Molly A. Maloy, MS, Gunjan L. Shah, MDMS, Hani Hassoun, MD, Sergio A. Giralt, MD, Heather J Landau, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4577.
https://doi.org/10.1182/blood-2019-129195
Published: 2019
Journal Articles

Anti-CD6 Monoclonal Antibody Itolizumab Efficiently Inhibits T Cell Proliferation after in Vitro TCR Stimulation in the Setting of Acute Graft Versus Host Disease

Benedetta Rambaldi, MD, Carol Reynolds, PhD, Sharmila Chamling Rai, BSc, Takeru Asano, MD PhD, Yohei Arihara, MD PhD, Mahasweta Gooptu, MD, John Koreth, MBBS, DPhil, Corey Cutler, MD MPH, FRCPC, Sarah Nikiforow, MD PhD, Vincent T. Ho, MD, Edwin P. Alyea, III, MD, Joseph H. Antin, MD, Rizwan Romee, MD PhD, Robert J. Soiffer, MD, Domenico Russo, MD, Jeanette Ampudia, BSc, Cherie Tracy Ng, PhD MPH, Stephen Connelly, PhD MBA, Jerome Ritz, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4517.
https://doi.org/10.1182/blood-2019-125721
Published: 2019
Journal Articles

Activation of AKT/mTOR Pathway in Ph+ Acute Lymphoblastic Leukemia (ALL) Leads to Non-Mutational Resistance

Afsar Ali Mian, BSc, MPhil, PhD, Usva Zafar, BSc, Oliver Ottmann, Prof, MD, Martin Ruthardt, MD, El-Nasir M A Lalani, BSc MBChB FRCPath PhDFHEA
Journal: Blood
Blood (2019) 134 (Supplement_1): 2570.
https://doi.org/10.1182/blood-2019-130898
Published: 2019
Journal Articles

Myeloid Neoplasms with t(12;22)(p13;q12) and MN1 Ectopia Are Refractory to Chemotherapy and Can Benefit from Hematopoietic Stem Cell Transplantation

Tong Wang, Xue Chen, MD, Shuang Hui, Jingbo Ni, Ying Yin, Wei Cao, Yan Zhang, Xinyu Wang, Xiaoli Ma, Panxiang Cao, Mingyue Liu, Kylan N. Chen, Fang Wang, MD, Yang Zhang, MD, Daijing Nie, MD, Lili Yuan, Hongxing Liu
Journal: Blood
Blood (2019) 134 (Supplement_1): 2721.
https://doi.org/10.1182/blood-2019-131610
Published: 2019
Journal Articles

Value of Flow Cytometry for MRD-Based Relapse Prediction in B-Cell Precursor Acute Lymphoblastic Leukemia in a Multi-Center Setting

Signe Modvig, MD PhD, Hans Madsen, Helene Hallböök, MD PhD, Sanna M. Siitonen, MD PhD, Liv T. N. Osnes, MD PhD, Susanne Rosthøj, PhD, Anne Tierens, MD PhD, Vesa Juvonen, PhD, Helen Vålerhaugen, Magnus Hultdin, MD PhD, Mats Ehinger, MD PhD, Anna Porwit, MD PhD, Reda Matuzeviciene, MD PhD, Mindaugas Stoskus, M Marincevic, PhD, Aili Lilleorg, PhD, Mervi Taskinen, MD PhD, Nina Toft, MD PhD, Ólafur Gísli Jónsson, MD PhD, Kaie Pruunsild, MD, Goda Elizabeta Vaitkeviciene, MD PhD, Kim Vettenranta, MD PhD, Bendik Lund, MD PhD, Jonas Abrahamsson, Kjeld Schmiegelow, Professor MD DMSc., Hanne Vibeke Marquart, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2755.
https://doi.org/10.1182/blood-2019-122311
Published: 2019
Journal Articles

Investigation of Homing Capacity As Prognostic Marker in Human Acute Myeloid Leukemia

Pauline Hanns, MSc, Marcelle Baer, MSc, Anna M Paczulla, PhD, Martina Konantz, PhD, Claudia Lengerke, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2701.
https://doi.org/10.1182/blood-2019-127647
Published: 2019
Journal Articles

Comparison of Acute Myeloid Leukemia Measurable Residual Disease Detection By Flow Cytometry in Peripheral Blood and Bone Marrow

Colin D. Godwin, MDMPhil, Yi Zhou, MD PhD, Megan Othus, PhD, Carole M. Shaw, BA, Kelda M. Gardner, PA-C, Brent L Wood, MD PhD, Roland B. Walter, MD PhD MS, Elihu H. Estey, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2729.
https://doi.org/10.1182/blood-2019-127128
Published: 2019
Journal Articles

Flow-Cytometry Based Detection of Any Minimal Residual Disease (FC-MRD) in Children with T-Acute Lymphoblastic Leukemias (T-ALL) Is a Powerful Indicator of Outcome

Prashant Tembhare, MD, Gaurav Narula, MD, Gaurav Chatterjee, MD, Twinkle Khanka, Mahima Sanyal, Sitaram Ghogale, Nikhil Patkar, MD, Nilesh Deshpande, Yajamanam Badrinath, Sumeet Gujral, MD, Shripad Banavali, MD, Papagudi Ganesan Subramanian, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2585.
https://doi.org/10.1182/blood-2019-128347
Published: 2019
Journal Articles

Comorbidities Reduce Response to Induction Treatment and Survival in Adults with Philadelphia-Negative Acute Lymphoblastic Leukemia

Ilaria Tanasi, Veronica Tagliaferri, Cristina Tecchio, Fiorenza Aprili, Giovanna De Matteis, Giovanni Pizzolo, Mauro Krampera, Massimiliano Bonifacio, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2587.
https://doi.org/10.1182/blood-2019-130160
Published: 2019
Journal Articles

Intravital Imaging of Bright Cyan-Fluorescent AML Model Reveals Impact of CXCR4 Inhibitor on AML and Immune Cell Dynamics

Tomasz Zal, PhD, Mateusz Rytelewski, PhD, Rodrigo Jacamo, PhD, Malgorzata Anna Zal, MSc, Meenakshi Shanmugasundaram, Michael Andreeff, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2674.
https://doi.org/10.1182/blood-2019-131945
Published: 2019